Last reviewed · How we verify

NCT04889586: MORE

Hand MOtor Rehabilitation Using a EMG-biofeedback: a Cross-sectional Study

Completed NA Last updated 17 May 2021
What this trial tests

NA trial testing EMG-biofeedback armband (REMO) in Stroke in 100 participants. Completed in 27 February 2019.

Timeline
25 July 2017
Primary endpoint
11 February 2019
27 February 2019

Quick facts

Lead sponsorIRCCS San Camillo, Venezia, Italy
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment100
Start date25 July 2017
Primary completion11 February 2019
Estimated completion27 February 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS San Camillo, Venezia, Italy

Who can join

18 and older, any sex, with Stroke or Stroke Hemorrhagic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recovery of upper limb and hand gestures is fundamental for autonomy restoration after stroke. Innovative technologies are a valid support for the delivery of rehabilitation treatments. Embedding surface electromyographic (sEMG) into wearable devices, allows the customisation of rehabilitation exercises, based on the clinical profile of each patient.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Features to Predict the Use of a sEMG Wearable Device (REMO<sup>®</sup>) for Hand Motor Training of Stroke Patients: A Cross-Sectional Cohort Study.
    Pregnolato G, Rimini D, Baldan F, Maistrello L, et al · · 2023 · cited 4× · PMID 36981992 · DOI 10.3390/ijerph20065082

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other IRCCS San Camillo, Venezia, Italy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04889586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing